Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially ...

No action is required by existing shareholders with respect to the name and ticker symbol change. The Committee on Uniform Securities Identification Procedures (CUSIP) also confirmed the CUSIP number ...

Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.

Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...

VANCOUVER - Rio Grande Resources, a spinoff from Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT), commenced trading on ...

The Dow was on pace for a 0.4% weekly gain, while the S&P 500 was up 0.5% so far and the Nasdaq Composite was 0.7% higher ...

The Nasdaq shows signs of uncertainty, with price action indicating a potential slowdown amid trade war concerns. See why I ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The Dow Jones Industrial Average finished with a gain of 317.24 points, or 0.7%, at 44,873.28, led by gains for Amgen, Goldman Sachs, Sherwin-Williams and Nvidia. The S&P 500 ended 23.60 points higher ...

MicorStrategy Inc. (NASDAQ:MSTR), the self-proclaimed bitcoin (BTC-USD) treasury company, changed its corporate name to Strategy as part of a rebranding effort, it said on Wednesday. The new name ...

Microsoft's stock price, trading between $400-450 for a couple of months now, is back to levels I consider reasonable for ...

Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.